At Adwya, development has always been a driving force for progress and a commitment to patients and to the medical and pharmaceutical professions, to provide them with therapeutic solutions that are ever more varied and ever more recent in terms of generics.

We are continually working on a development pipeline of 60 to 80 new molecules and on expanding our know-how and our range of technological and industrial skills.

In addition, to meet specific emerging needs in terms of well-being, we are developing a wide and innovative range of food supplements in which research plays a key role.

With more than 30 years’ experience on the national territory, Adwya has set itself the challenge of expanding internationally, making exports one of its strategic areas of development.

We are active in Libya, West Africa and Iraq. We are working to consolidate our position in these markets and to open up new ones.